Alerts will be sent to your verified email
Verify EmailRESONANCE
|
Resonance Specialtie
|
Par Drugs & Chem.
|
Polson
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.83 % | 16.79 % | 5.26 % |
|
5yr average Equity Multiplier
|
1.22 | 1.28 | 1.58 |
|
5yr Average Asset Turnover Ratio
|
1.06 | 0.92 | 0.5 |
|
5yr Avg Net Profit Margin
|
10.72 % | 14.32 % | 6.56 % |
|
Price to Book
|
1.86 | 1.04 | 1.05 |
|
P/E
|
16.51 | 11.42 | 26.48 |
|
5yr Avg Cash Conversion Cycle
|
111.92 Days | -12.24 Days | 31.08 Days |
|
Inventory Days
|
98.79 Days | 16.4 Days | 77.75 Days |
|
Days Receivable
|
83.71 Days | 48.97 Days | 50.55 Days |
|
Days Payable
|
91.05 Days | 90.62 Days | 97.28 Days |
|
5yr Average Interest Coverage Ratio
|
78.86 | 113.93 | 2.7 |
|
5yr Avg ROCE
|
19.79 % | 20.52 % | 8.44 % |
|
5yr Avg Operating Profit Margin
|
15.26 % | 22.04 % | 16.59 % |
|
5 yr average Debt to Equity
|
0.04 | 0.03 | 0.41 |
|
5yr CAGR Net Profit
|
-8.99 % | 2.85 % | -9.32 % |
|
5yr Average Return on Assets
|
12.27 % | 13.02 % | 3.31 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.25 % | 73.41 % | 74.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.8 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Resonance Specialtie
|
Par Drugs & Chem.
|
Polson
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Customer Wise Break-Up
|
Customer Wise Break-Up
|
-
|
-
|